Given that current research suggests that GSDMD-mediated pyroptosis is a major promoter of OSA-related diseases, targeting the inhibition of GSDMD may help avoid the negative effects associated with inhibiting other gasdermin proteins, while still preserving GSDMD’s normal physiological functions. This evidence concerns the gene GSDMD and obstructive sleep apnea syndrome.